(O-27) PRELIMINARY DATA ON THE USE OF PLATELET-RICH PLASMA IN PENIS FOR ERECTILE DYSFUNCTION OF VASCULAR ORIGIN

After conducting an exhaustive review of the literature published to date, we decided to evaluate the effects of acute exposure to autologous PRP on erectile function and assess the impact of this therapeutic strategy in patients with erectile dysfunction of mild-moderate vascular origin. All patients who participated in our study completed the IIEF 5 questionnaire prior to the procedure. autologous venous blood was extracted, the sample was processed and activated with 10% calcium chloride solution. After local anesthesia in the trunk of the penis shaft with benzocaine and xylocaine. 8 ml of PRP was applied to 9 patients, with a 25G needle, distributed in 4 applications. 2 applications in each cavernous body, one in the distal region and another in the proximal regionsThe designed protocol indicates: 4 applications spaced by 15 days. The 9 patients complied with all applications. The average age of the patients was 68.7 years (range 58-77). The IIEF-5 average prior to applications was 14.6.One month after completing the complete protocol, the IIEF-5 score showed a result of 18.9. This type of procedure, being an autologous treatment and not having relevant complications, could be a promising therapeutic strategy for patients with erectile dysfunction of mild-moderate vascular origin, as long as expectations are explained and health is addressed. integral to avoid the eventual progressive deterioration of the endothelium. No conflict.